Literature DB >> 6890682

Stress-induced facilitation of acoustic startle after d-amphetamine administration.

L Kokkinidis, E P MacNeill.   

Abstract

Administration of d-amphetamine enhanced the startle response to an auditory stimulus. In contrast to saline treated mice, startle activity after amphetamine administration did not wane with repeated exposure to the auditory stimulus. Rather, the effects of amphetamine on startle activity increased as a function of stimulus presentation. Whereas exposure to isolation stress or inescapable shock had no effect on startle activity, both types of stress potentiated the effects of amphetamine on startle arousal. The observation that stress sensitized animals to later amphetamine administration is consistent with the effects of stress on other amphetamine behaviors, e.g., stereotypy. Results were related to the development of dopamine post-synaptic receptor supersensitivity after exposure to stress and were discussed in terms of the role played by stress in the expression of behavioral arousal, in the etiology of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6890682     DOI: 10.1016/0091-3057(82)90297-0

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  3 in total

1.  Amphetamine-induced perseverative behavior in a radial arm maze following DSP4 or 6-OHDA pretreatment.

Authors:  V Bruto; C Beauchamp; R M Zacharko; H Anisman
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

2.  Nicotine modulates effects of stress on acoustic startle reflexes in rats: dependence on dose, stressor and initial reactivity.

Authors:  J B Acri
Journal:  Psychopharmacology (Berl)       Date:  1994-11       Impact factor: 4.530

3.  Behavioral evidence implicating dopamine in sensorimotor arousal and norepinephrine in the sedative effects of antidepressant drugs.

Authors:  L Kokkinidis; B D McCarter
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.